Chinese Clinical Laboratories Market, Forecast to 2025

Chinese Clinical Laboratories Market, Forecast to 2025

Investment in Private and Specialty Care Clinics Drives Growth

RELEASE DATE
04-Apr-2019
REGION
Asia Pacific
Research Code: 9AB9-00-B5-00-00
SKU: HC03157-AP-MR_23000

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC03157-AP-MR_23000

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

China is one of the fastest growing healthcare markets in the world. Traditionally, healthcare services have been dominated by the public sector; however, 2014 onward, the trend reversed with greater private sector participation. China still faces a number of challenges: unequal distribution of healthcare resources across the country; lack of an effective primary care system; expensive healthcare; poor conditions of healthcare facilities; and poor service. Urbanization, environmental pollution, and wealth disparities have led to widespread health problems, including a significant rise in chronic diseases.

In response to these rapidly emerging challenges, China has upgraded its healthcare services and expanded its health expenditures. In addition, the Chinese Government has launched a series of healthcare reforms which includes health insurance reforms, primary care reforms, hospital reforms, medications and public health. To boost the private hospital industry, the government has introduced various policies and reform measures to encourage private and foreign ownership of hospitals and improve the medical talent pool in the private sector.

The main source of revenue for clinical laboratory testing market in China is generated by hospital laboratories. Tests from hospitals’ inpatients and outpatients will continue to be the largest contributor of revenue and volume of clinical laboratory testing during the forecast period. China represents high growth opportunity, as clinical laboratories are undergoing radical changes in adopting high-end technology and automation. Independent labs will witness tremendous growth as a result of the increased diagnostic test consumption and the outsourcing of complicated pathological tests. China is seeing a rapid growth in private hospital infrastructure, which is being driven in order to reduce the over-utilization and over-reliance of Chinese citizens on public hospital system. The government had introduced several key reforms that are aimed at shaping the clinical diagnostics industry and to support the growth and investment in the private sector. The government is also upgrading the medical devices of hospitals and purchasing essential medical equipment for rural hospitals.

Key Issues Addressed

  • How has China’s clinical labs market changed over the years?
  • What impact will new regulations have on labs? What are the new procedures that need to be adopted to gain approvals? How would this affect manufacturers?
  • Which is the type of testing that is experiencing maximum growth and why?
  • What are the new business models that can change care delivery?
  • Which are the segments that are opportunistic for manufacturer sales?
  • What were the acquisition trends witnessed in the last few years? How will this change?

Table of Contents

Key Findings

Key Trends

Key Questions this Study will Answer

Executive Summary—Market Engineering Measurements

Key Companies to Watch

3 Big Predictions

Scope and Segmentation

Market Segmentation

Market Segmentation (continued)

Market Overview

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Market Overview (continued)

Impact of Trends on Clinical Laboratories Market

Defining Healthcare Trends in the Future

Defining Healthcare Trends in the Future (continued)

Market Drivers

Market Restraints

Impact Mapping of Drivers and Restraints

Chinese Clinical Laboratory—Regulatory Overview

Healthcare Direct Foreign Investment Regulations

Market Engineering Measurements

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast Discussion

Market Share Analysis

Competitive Structure

Clinical Laboratories Market Access in China—Game-changing Strategies

Merger, Acquisition, and Partnership Assessment

Company Profile—KingMed Diagnostics

Company Profile—DIAN Diagnostics

Company Profile—ADICON Laboratories

Industry Value Chain

Major Growth Opportunities

Growth Opportunity 1—Data Management

Growth Opportunity 2—Clinical Lab Automation

Growth Opportunity 3—Public and Independent Lab Partnership

Growth Opportunity 4—Interoperability and Standardization

Growth Opportunity 5—Test Type

Growth Opportunity 5—Test Type (continued)

Strategic Imperatives for China’s Clinical Laboratories Market

3 Big Predictions

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
China is one of the fastest growing healthcare markets in the world. Traditionally, healthcare services have been dominated by the public sector; however, 2014 onward, the trend reversed with greater private sector participation. China still faces a number of challenges: unequal distribution of healthcare resources across the country; lack of an effective primary care system; expensive healthcare; poor conditions of healthcare facilities; and poor service. Urbanization, environmental pollution, and wealth disparities have led to widespread health problems, including a significant rise in chronic diseases. In response to these rapidly emerging challenges, China has upgraded its healthcare services and expanded its health expenditures. In addition, the Chinese Government has launched a series of healthcare reforms which includes health insurance reforms, primary care reforms, hospital reforms, medications and public health. To boost the private hospital industry, the government has introduced various policies and reform measures to encourage private and foreign ownership of hospitals and improve the medical talent pool in the private sector. The main source of revenue for clinical laboratory testing market in China is generated by hospital laboratories. Tests from hospitals’ inpatients and outpatients will continue to be the largest contributor of revenue and volume of clinical laboratory testing during the forecast period. China represents high growth opportunity, as clinical laboratories are undergoing radical changes in adopting high-end technology and automation. Independent labs will witness tremendous growth as a result of the increased diagnostic test consumption and the outsourcing of complicated pathological tests. China is seeing a rapid growth in private hospital infrastructure, which is being driven in order to reduce the over-utilization and over-reliance of Chinese citizens on public hospital system. The government had introduced several key reforms t
More Information
No Index No
Podcast No
Author Sanjeev Kumar
Industries Healthcare
WIP Number 9AB9-00-B5-00-00
Is Prebook No
GPS Codes 9600-B1,99C1-B1,99C6-B1,9837-B1,9611-B1,9627-B1